Introduction: Motor neuron disease (MND) is a progressive, incurable disease, characterised by degeneration of the nerves in the brain and spinal cord. Due to the multisystem effects of the disease, patients are faced with many complex, time-sensitive decisions, one of which is the decision on gastrostomy feeding. There are currently no published decision aids (DAs) to support patients making this decision in the UK. This study will develop and pilot a patient DA to provide evidence-based information on gastrostomy placement and feeding that is relevant to people with MND; communicate the risks and benefits associated with each option; check understanding and clarify personal values and preferences, enabling patients to make a decision cong...
Abstract Background Self-management support (SMS) forms a central pillar in the management of long-t...
Objectives To evaluate the processes involved in using a novel digitally enabled healthcare system (...
BackgroundGastrostomy is recommended in amyotrophic lateral sclerosis for long-term nutritional supp...
Introduction: Motor neuron disease (MND) is a progressive, incurable disease, characterised by degen...
Introduction: Motor neurone disease (MND) is a progressive, incurable disease, characterised by dege...
Motor neuron disease (MND) is a progressive, incurable disease, characterised by degeneration of the...
Introduction: Motor neuron disease (MND) is a progressive, incurable disease, characterised by degen...
Objectives: Gastrostomy decision making is a complicated, multifaceted process for people with motor...
Introduction: Motor neuron disease (MND) is a terminal, progressive, multisystem disorder. Well-time...
Introduction: Motor neuron disease (MND) is aterminal, progressive, multisystem disorder. Well-timed...
A pathway has been developed using a multidisciplinary group from within specialist palliative care ...
Purpose: Healthcare decision making in motor neurone disease (MND) focuses on symptom management an...
Abstract Background People with motor neuron disease (pwMND) are routinely offered gastrostomy feedi...
Background The diagnosis of motor neurone disease (MND) is known to be challenging and there may be...
This paper provides an overview of the nutritional management and care of people living with motor n...
Abstract Background Self-management support (SMS) forms a central pillar in the management of long-t...
Objectives To evaluate the processes involved in using a novel digitally enabled healthcare system (...
BackgroundGastrostomy is recommended in amyotrophic lateral sclerosis for long-term nutritional supp...
Introduction: Motor neuron disease (MND) is a progressive, incurable disease, characterised by degen...
Introduction: Motor neurone disease (MND) is a progressive, incurable disease, characterised by dege...
Motor neuron disease (MND) is a progressive, incurable disease, characterised by degeneration of the...
Introduction: Motor neuron disease (MND) is a progressive, incurable disease, characterised by degen...
Objectives: Gastrostomy decision making is a complicated, multifaceted process for people with motor...
Introduction: Motor neuron disease (MND) is a terminal, progressive, multisystem disorder. Well-time...
Introduction: Motor neuron disease (MND) is aterminal, progressive, multisystem disorder. Well-timed...
A pathway has been developed using a multidisciplinary group from within specialist palliative care ...
Purpose: Healthcare decision making in motor neurone disease (MND) focuses on symptom management an...
Abstract Background People with motor neuron disease (pwMND) are routinely offered gastrostomy feedi...
Background The diagnosis of motor neurone disease (MND) is known to be challenging and there may be...
This paper provides an overview of the nutritional management and care of people living with motor n...
Abstract Background Self-management support (SMS) forms a central pillar in the management of long-t...
Objectives To evaluate the processes involved in using a novel digitally enabled healthcare system (...
BackgroundGastrostomy is recommended in amyotrophic lateral sclerosis for long-term nutritional supp...